TPG to acquire 35% stake in SCHOTT Poonawalla from Serum Institute of India

TPG Growth is set to acquire a 35% stake in SCHOTT Poonawalla from Serum Institute of India, with Novo Holdings co-investing. This deal aims to bolster the drug containment firm's growth in India and globally. Serum Institute will retain a minority stake, while SCHOTT Pharma remains the controlling stakeholder, leveraging TPG's healthcare expertise.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/RWZK3ov
via IFTTT